慢性心力衰竭的循证诊疗与管理

心血管疾病已经成为我国城乡居民的首要死亡原因，给人民和社会的带来的经济负担日益加重。其中，心力衰竭作为诸多心血管疾病的终末阶段，是二十一世纪最重要的心血管病之一，其死亡率和癌症相当，是严重影响人民健康的重要公共卫生问题。近年来，心血管病学领域取得了巨大进展。基础医学及相关学科的发展，进一步丰富了对心血管疾病发病和病理生理机制的认识。心力衰竭领域的进展一日千里，有鉴于此，我们亟需一本能反映此领域最新循证医学进展的专著，以供广大心血管专科医师参考。本书围绕慢性心力衰竭这个主题，重点关注慢性心衰的临床诊疗及管理，介绍慢性心力衰竭的流行病学、病理生理机制最新药物和非药物治疗进展、康复及管理理念，并结合心衰不同病因及合并疾病情况进行介绍，尽可能的反映出近年来慢性心衰领域的前沿诊疗措施和技术。

主编徐俊波主任医师，系四川省“天府名医”、四川省学术和技术带头人、四川省卫生健康领军人才、四川省卫健委学术技术带头人、成都市卫健委学术技术带头人、享受成都市人民政府特殊津、中国医院协会2016年优秀医院院长、“国家卫健委医疗管理服务指导专家库”成员、中国医院协会国际医疗服务与管理专业委员会常务委员，中国高血压联盟理事，中国高血压及相关疾病中青年专家论坛CHIEF成员、中国心脏康复联盟四川分盟主任委员、四川省医师协会副会长、四川省医师协会心血管专业委员会主任委员、、四川省医学会心血管专业委员会副主任委员、四川省中西医结合心血管专业委员会主任委员，成都市医学会心血管专业委员会副主任委员，《心血管病学进展》主编。主持/主研省市各级课题、横向课题、国际多中心研究10多项，获省、市科技进步奖4项，授权国家发明专利6项，实用新型专利6项。发表学术论文100余篇，SCI收录论文10多篇，中文核心期刊论文逾40篇，。主编/参编学术专著4部，已培养硕士研究生12名。

\"第一章　慢性心力衰竭的流行病学 ······················································································· 1 第二章　慢性心力衰竭的病理生理机制 ················································································ 10 第三章　慢性心力衰竭的诊断和评估 ··················································································· 17 第一节　慢性心力衰竭诊断概述 ··················································································· 17 第二节　超声心动图诊断 ···························································································· 21 第三节　放射学诊断 ·································································································· 31 第四节　慢性心力衰竭的评估 ······················································································ 56 第四章　慢性心力衰竭的药物治疗 ······················································································ 86 第一节　血管紧张素转换酶（受体、受体脑啡肽酶）抑制剂 ··············································· 86 第二节　β受体阻滞剂 ······························································································ 105 第三节　钠.-葡萄糖耦联转运体 2抑制剂 ······································································ 121 第四节　盐皮质激素受体拮抗剂 ················································································· 130 第五节　正性肌力药物 ····························································································· 146 第六节　利尿剂······································································································· 158 第七节　药物方案的调整及优化 ················································································· 162 第五章　慢性心力衰竭的非药物治疗 ················································································· 168 第一节　连续性肾脏替代治疗 ···················································································· 168 第二节　起搏治疗 ··································································································· 179 第三节　心脏收缩力调节器 ······················································································· 197 第四节　主动脉内球囊反搏 ······················································································· 205 第五节　体外膜肺氧合 ······························································································211 第六节　微轴向心室辅助装置（以 Impella为例） ··························································· 219 第七节　颈动脉窦刺激及交感节神经消融 ····································································· 230 第八节　二尖瓣外科成形术及介入技术 ········································································ 238 第九节　左心室减容术 ····························································································· 249 第十节　心室辅助装置 ····························································································· 257 第十一节　心脏移植 ································································································ 265 第六章　慢性心力衰竭合并其他疾病 ················································································· 276 第一节　高血压······································································································· 276 第二节　冠心病······································································································· 284 第三节　心房颤动 ··································································································· 293 第四节　糖尿病······································································································· 316 第五节　肥厚型心肌病 ····························································································· 330 第六节　扩张型心肌病 ····························································································· 340 第七节　心脏淀粉样变性 ·························································································· 360 第八节　炎症性心肌病 ····························································································· 366 第九节　心肾综合征 ································································································ 376 第十节　呼吸系统疾病 ····························································································· 387 第十一节　甲状腺疾病 ····························································································· 404 第十二节　肺动脉高压 ····························································································· 413 第十三节　瓣膜性心脏病 ·························································································· 431 第十四节　抗肿瘤治疗相关心力衰竭 ··········································································· 443 第十五节　结缔组织疾病 ·························································································· 455 第七章　慢性心力衰竭的康复治疗 ··································································